Impact of Light Chain Isotype on Clinical Features and Outcomes in Systemic AL Amyloidosis

Hopson, M., Bhutani, D., Sarkaria, S. M., Maurer, M., Griffin, J., Lentzsch, S., & Chakraborty, R. (2021). Impact of Light Chain Isotype on Clinical Features and Outcomes in Systemic AL Amyloidosis. Blood, 138(Supplement 1), 4726–4726. https://doi.org/10.1182/blood-2021-149299
Authors:
Madeleine Hopson
Divaya Bhutani
Shawn Sarkaria
Mathew S. Maurer
Jan M. Griffin
Suzanne Lentzsch
Rajshekhar Chakraborty
Affiliated Authors:
Madeleine Hopson
Divaya Bhutani
Shawn Sarkaria
Mathew S. Maurer
Jan M. Griffin
Suzanne Lentzsch
Rajshekhar Chakraborty
Columbia Affiliation:
Subjects:
Molecular Mechanisms of Amyloidosis (OpenAlex Topic)
Mineral Metabolism in Chronic Kidney Disease (OpenAlex Topic)
Epidemiology and Management of Neuroendocrine Tumors (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1182/blood-2021-149299
DOI:
10.1182/blood-2021-149299
Journal:
Blood
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: